Georgia Erbez
Chief Financial Officer and Chief Business Officer
Replay available
Codexis, Inc. (NASDAQ: CDXS) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.

Chief Financial Officer and Chief Business Officer
President and Chief Executive Officer
Chief Scientific Officer
Senior Vice President, Sales and Marketing
Piper Sandler Analyst
Craig Hallum Analyst
Jefferies Analyst
Stifel Analyst
TD Cowan Analyst (for Brendan Smith)
Greetings and welcome to the Codex's second quarter 2026 financial results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow a formal presentation. If anyone should require operator assistance during the conference, press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Georgia Erbez, Chief Financial Officer and Chief Business Officer. Thank you. You may begin. Thank you, Operator. With me today are Alison Moore, President and Chief Executive Officer, Stefan Lutz, Chief Scientific Officer, and Britton Jimenez, Senior Vice President, Sales and Marketing. During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our guidance for 2026 revenue, anticipated milestones and product launches, facility expansions, technical milestones, and public announcements related thereto, as well as our strategies and prospects for revenue growth, path to profitability, and successful execution of current and future programs and partnerships. To the extent that statements contained in this call are not descriptions of historical facts regarding Codexys, They are forward-looking statements reflecting the beliefs and expectations of management as of the statement date, August 11, 2026. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond Codexys' control that could materially affect actual results. Additional information about factors that could materially affect actual results can be found in Codexys filings with th...